References
- Aue-Aungkul A, Punyawatanasin S, Natprathan A, et al (2011). "See and treat" approach is appropriate in women with highgrade lesions on either cervical cytology or colposcopy. Asian Pac J Cancer Prev, 12, 1723-6.
- Carozzi F, De Marco L, Gillio-Tos A, et al (2014). Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. J Clin Virol, 60, 257-63. https://doi.org/10.1016/j.jcv.2014.04.009
- Castle PE, Fetterman B, Poitras N, et al (2009). Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol, 113, 595-600. https://doi.org/10.1097/AOG.0b013e3181996ffa
- Chiang YC, Cheng WF, Chen YL, et al (2013). High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions. Taiwan J Obstet Gynecol, 52, 222-6. https://doi.org/10.1016/j.tjog.2013.04.012
- de Sanjose S, Wheeler CM, Quint WG, et al (2013). Age-specific occurrence of HPV16- and HPV18-related cervical cancer. Cancer Epidemiol Biomarkers Prev, 22, 1313-8. https://doi.org/10.1158/1055-9965.EPI-13-0053
- Hamzi Abdul Raub S, Isa NM, Zailani HA, et al (2014). Distribution of HPV genotypes in cervical cancer in multiethnic Malaysia. Asian Pac J Cancer Prev, 15, 651-6. https://doi.org/10.7314/APJCP.2014.15.2.651
- Ingkapairoj N, Luanratanakorn S, Chumworathayi B, et al (2012). Incidences of cervical intraepithelial neoplasia 2-3 or cancer pathologic diagnoses in patients with a high grade squamous intraepithelial lesion pap smear attending a colposcopy clinic at srinagarind hospital. Asian Pac J Cancer Prev, 13, 6203-6. https://doi.org/10.7314/APJCP.2012.13.12.6203
- Kietpeerakool C, Cheewakriangkrai C, Suprasert P, et al (2009). Feasibility of the 'see and treat' approach in management of women with 'atypical squamous cell, cannot exclude high-grade squamous intraepithelial lesion' smears. J Obstet Gynaecol Res, 35, 507-13. https://doi.org/10.1111/j.1447-0756.2008.00992.x
- Massad LS, Einstein MH, Huh WK, et al (2013). 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol, 121, 829-46. https://doi.org/10.1097/AOG.0b013e3182883a34
- Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northeast Thailand. Asian Pac J Cancer Prev, 14, 6961-4. https://doi.org/10.7314/APJCP.2013.14.11.6961
- Poomtavorn Y, Suwannarurk K, Thaweekul Y, et al (2011). Risk factors for high-grade cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance (ASC-US) Papanicolaou smears. Asian Pac J Cancer Prev, 12, 235-8.
- Saraiya M, Benard VB, Greek AA, et al (2014). Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies. Am J Obstet Gynecol, [Epub ahead of print].
- Siriaunkgul S, Utaipat U, Suwiwat S, et al (2012). Prognostic value of HPV18 DNA viral load in patients with early-stage neuroendocrine carcinoma of the uterine cervix. Asian Pac J Cancer Prev, 13, 3281-5. https://doi.org/10.7314/APJCP.2012.13.7.3281
- Sui S, Jiao Z, Niyazi M, et al (2013). Genotype distribution and behavioral risk factor analysis of human papillomavirus infection in Uyghur women. Asian Pac J Cancer Prev, 14, 5861-5. https://doi.org/10.7314/APJCP.2013.14.10.5861
- Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, et al (2011). Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women. Asian Pac J Cancer Prev, 12, 853-6.
- Tabrizi SN, Brotherton JM, Stevens MP, et al (2014). HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. J Clin Virol, 60, 250-6. https://doi.org/10.1016/j.jcv.2014.04.013
- Wiley DJ, Masongsong EV, Lu S, et al (2012). Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections. Cancer Epidemiol, 36, 183-9. https://doi.org/10.1016/j.canep.2011.09.003
Cited by
- Histologic Outcomes in HPV-Positive and Cervical Cytology-Negative Women - Screening Results in Northern Thailand vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7271
- High-grade Cervical Histopathology in Women with Atypical Glandular Cell Cytology vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.135
- The Importance of High-Risk Human Papillomavirus Types Other Than 16 and 18 in Cervical Neoplasia vol.142, pp.6, 2018, https://doi.org/10.5858/arpa.2017-0563-RA